Skip To Main Content
Campus Sverige
  • Terapiområde
Campus Sverige
  • Terapiområde
View Full Results

ECTRIMS 2026: Key Highlights

Author

:

Sanofi

Editorial team

10th Joint ACTRIMS-ECTRIMS Meeting Toronto, 21-23 October 2026.

Following ACTRIMS–ECTRIMS 2026, leading European MS experts discuss key highlights and emerging evidence with a focus on their relevance to clinical practice for neurologists in North Europe. Hosted by Professor Pietro Maggi, this webinar brings together MS experts from across Northern Europe.

Expert perspectives

Read the key topics presented by Nordic experts at MSToronto 2026, including MS progression, biomarkers, real-world data and imaging.

Maggi

Prof. Pietro Maggi, MD, PhD, Associate Professor

Clinical Neurology, UCLouvain, and Neurologist, Cliniques Universitaires Saint-Luc, Brussels

  • Welcome and introduction to program and experts highlights of ECTRIMS
Zsolt

Prof. Zsolt Illés, MD, PhD, DSc

Professor, University of Southern Denmark, and Consultant Neurologist, Odense University Hospital

  • Composite of markers to predict disease progression in secondary progressive multiple sclerosis
Forsberg

Lars Forsberg, PhD

Research Specialist, Karolinska Institutet

  • Advancing prediction of progression independent of relapses in multiple sclerosis by integrating clinical data and patient-reported outcomes
Emilie

Emilie Friberg, PhD, Associate Professor

Principal Researcher, Karolinska Institutet

  • Understanding MS phenotypes and economic burden (analysis from the Swedish MS Registry)
Sini

Sini Laakso, MD, PhD, Associate Professor

Specialist in neurology, Helsinki University Hospital, and research group leader, University of Helsinki

  • MSToronto highlights: imaging updates and key takeaways
Sofia

Sofia Sandgren, MD, PhD

Researcher, University Hospital and University of Basel; affiliated with the University of Gothenburg and Sahlgrenska University Hospital

  • Identification of new promising fluid biomarker candidates to capture progression in MS patients through targeted (Olink, Nulisa) and non-targeted (mass spectrometry) proteomics

 

Watch the webinar

Watch the full webinar recording in which leading European MS experts discuss key ACTRIMS–ECTRIMS 2026 highlights, moderated by Professor Pietro Maggi.

MAT-BE-2601304

Relaterade Artiklar

Slowly Expanded Lesions

Slowly Expanded Lesions

A candidate biomarker for smoldering neuroinflammation in MS.

Läs mer
Multiple sclerosis progression: time for a new mechanism-driven framework

Multiple sclerosis progression: time for a new mechanism-driven framework

Paper by Tanja Kuhlmann et al.

Läs mer
Smouldering multiple sclerosis

Smouldering multiple sclerosis

Läs mer
MAT-SE-2600552